全体要約
化粧品用筋弛緩剤市場は、2022年の売上を基に、2023年から2029年にかけての地域別および市場セクター別の予測を提供します。市場は、植物の花や種の抽出物を含む製品タイプに分かれ、男性用および女性用化粧品に応用されます。アメリカ、中国、ヨーロッパの市場はそれぞれ成長が見込まれています。
主要企業には、All Organic Treasures、Givaudan、Gattefosséなどがあり、2022年には上位2社が市場の大部分を占めました。このレポートは、化粧品用筋弛緩剤の市場シェア、成長機会、製品タイプ、アプリケーション、地域別の詳細な分析を提供し、業界の動向や企業戦略を明らかにします。
関連する質問
All Organic Treasures, BioOrganic Concepts, Biogründl, Botanic Innovations, Chemir, Esperis, Gattefossé, Givaudan, Green Angel, Green Source Organics, Linnea, Lubrizol, Macrocare Tech, Phyto Life Sciences, Sensient Cosmetic Technologies, Hunan Health-Guard Bio-Tech
製品セグメンテーションのトレンド, 地域別市場成長の要因, 競争力のある企業戦略
概要
LPI (LP Information)の最新の調査レポート「化粧品業界向けミオリラクシング剤の予測」では、過去の販売状況を分析し、2022年の世界のミオリラクシング剤の売上を確認しています。そして、2023年から2029年までの予測売上について地域別および市場セクター別の包括的な分析を提供。ミオリラクシング剤の売上は地域、市場セクターおよびサブセクターごとに分けられており、このレポートでは世界のミオリラクシング剤業界の詳細な分析を百万米ドル単位で提供。
このインサイトレポートは、グローバルな化粧品用筋弛緩剤の景観に関する包括的な分析を提供し、製品セグメンテーション、企業形成、収益、市場シェア、最新の開発、M&A活動に関連する主要なトレンドを強調しています。また、レポートは、化粧品用筋弛緩剤のポートフォリオと能力、市場参入戦略、市場ポジション、地理的足跡に焦点を当て、世界的な化粧品用筋弛緩剤市場が加速する中で、これらの企業の独自の立場をより良く理解するために、主要なグローバル企業の戦略を分析します。
このインサイトレポートは、化粧品用筋弛緩剤の世界的な展望を形作る重要な市場動向、ドライバー、影響要因を評価し、タイプ、用途、地理、そして市場規模によって予測を分解し、新たな機会のポケットを浮き彫りにします。数百のボトムアップの定性および定量的市場インプットに基づいた透明な方法論を用いたこの研究予測は、化粧品用筋弛緩剤の現状と将来の軌道について非常に詳細な見解を提供します。
世界の化粧品用筋弛緩剤市場の規模は、2022年のXX米ドルから2029年のXX米ドルへと成長することが予測されています。2023年から2029年までの間にCAGR%で成長すると期待されています。
アメリカの化粧品用筋弛緩剤市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年までの年平均成長率（CAGR）はXX%です。
中国の化粧品用筋弛緩剤市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%のCAGRで成長する見込みです。
ヨーロッパの化粧品用ミオレラキシング剤市場は、2022年のXX米ドルから、2029年にはXX米ドルに増加すると推定されており、2023年から2029年までの間にXX%のCAGRで成長する見込みです。
グローバルな主要なコスメ用筋弛緩剤のプレイヤーには、オールオーガニックトレジャーズ、バイオオーガニックコンセプツ、ビオグリュンドル、ボタニックイノベーションズ、ケミール、エスペリス、ガッテフォセ、ジボダン、グリーンエンジェルなどが含まれます。収益の観点から、2022年には世界の2大企業が占めるシェアはほぼXX%です。
この報告は、製品タイプ、アプリケーション、主要メーカー、および主要地域と国別の化粧品用筋弛緩剤市場の包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション
タイプ別セグメンテーション
植物の花びら抽出物
植物種子抽出物
その他
アプリケーション別セグメンテーション
男性用化粧品
女性用化粧品
この報告書では、市場を地域別に分けています。
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、プライマリーエキスパートからの情報収集や、企業のカバレッジ、製品ポートフォリオ、市場浸透率の分析に基づいて選定されました。
オーガニックトレジャーズ全部
バイオオーガニックコンセプト
バイオグリュンドル
植物の革新
ケミル
エスペリス
ガッテフォッセ
ジボダン
グリーンエンジェル
グリーンソースオーガニクス
リネア
ルブリゾール
マクロケアテック
フィトライフサイエンス
センシエント・コスメティック・テクノロジーズ
湖南ヘルスガードバイオテック
本報告書で扱った重要な質問
化粧品用筋弛緩剤市場の10年間の展望は何ですか？
マイオリラクシング剤の化粧品市場の成長を促進している要因は何ですか？世界的および地域別に。
どの技術が市場と地域ごとに最も早く成長する準備ができていますか？
化粧品用ミオリラクサント市場の機会は、エンド市場の規模によってどのように異なりますか？
コスメティック用ミオリラクシング剤のタイプおよび用途の内訳はどのようになっていますか？
COVID-19とロシア・ウクライナ戦争の影響は何ですか？
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルの化粧品用筋弛緩剤、年間売上、2018年～2029年
2.1.2 化粧品用筋弛緩剤の世界市場の現状分析・将来予測、地理別、2018年、2022年および2029年
2.1.3 化粧品用筋弛緩剤の世界市場の現状分析・将来予測、国・地域別、2018年、2022年および2029年
2.2 化粧品用筋弛緩剤セグメント、タイプ別
2.2.1
2.2.2
2.2.3 その他
2.3 化粧品用筋弛緩剤の売上、タイプ別
2.3.1 グローバルにおける化粧品用筋弛緩剤の売上・市場シェア、タイプ別（2018年～2023年）
2.3.2 化粧品用筋弛緩剤のグローバルレベニュー・市場シェア、タイプ別（2018～2023年）
2.3.3 グローバルの化粧品用筋弛緩剤、販売価格（タイプ別）（2018年～2023年）
2.4 化粧品用筋弛緩剤セグメント、用途別
2.4.1
2.4.2
2.5 化粧品用筋弛緩剤の売上、用途別
2.5.1 グローバルの化粧品用筋弛緩剤、収益・市場シェア（用途別）（2018年～2023年）
2.5.2 化粧品用筋弛緩剤のグローバルレベニュー・市場シェア、用途別（2018～2023年）
2.5.3 グローバルの化粧品用筋弛緩剤、販売価格（用途別）（2018年～2023年）
3 グローバルにおける化粧品用筋弛緩剤、企業別
3.1 グローバルにおける化粧品用筋弛緩剤市場のブレークダウンデータ、企業別
3.1.1 グローバルにおける化粧品用筋弛緩剤の年間売上、企業別（2018年～2023年）
3.1.2 グローバルにおける化粧品用筋弛緩剤の売上・市場シェア、企業別（2018年～2023年）
3.2 グローバルにおける化粧品用筋弛緩剤の年間収益、企業別（2018年～2023年）
3.2.1 グローバルにおける化粧品用筋弛緩剤市場の収益規模、企業別（2018年～2023年）
3.2.2 グローバルにおける化粧品用筋弛緩剤市場の収益シェア、企業別（2018年～2023年）
3.3 グローバルにおける化粧品用筋弛緩剤の販売価格、企業別
3.4 化粧品用筋弛緩剤の主要メーカー、生産地域分布、販売地域、製品タイプ
3.4.1 化粧品用筋弛緩剤の主要メーカー、製品と拠点の分布
3.4.2 プレイヤーが提供している化粧品用筋弛緩剤製品
3.5 市場集中度分析
3.5.1 競合情勢分析
3.5.2 集中度レシオ（CR3、CR5、CR10）（2018年～2023年）
3.6 新製品・潜在的参入
3.7 M&A、拡大
4 化粧品用筋弛緩剤の世界市場過去推移レビュー、地理別
4.1 化粧品用筋弛緩剤の世界市場規模の過去推移、地理別（2018年～2023年）
4.1.1 グローバルにおける化粧品用筋弛緩剤の年間売上、地理別（2018年～2023年）
4.1.2 グローバルにおける化粧品用筋弛緩剤の年間収益、地理別（2018年～2023年）
4.2 化粧品用筋弛緩剤の世界市場規模の過去推移、国・地域別（2018年～2023年）
4.2.1 グローバルにおける化粧品用筋弛緩剤の年間売上、国・地域別（2018年～2023年）
4.2.2 グローバルにおける化粧品用筋弛緩剤の年間収益、国・地域別（2018年～2023年）
4.3 アメリカズにおける化粧品用筋弛緩剤の売上成長
4.4 APACにおける化粧品用筋弛緩剤の売上成長
4.5 ヨーロッパにおける化粧品用筋弛緩剤の売上成長
4.6 中東・アフリカにおける化粧品用筋弛緩剤の売上成長
5 アメリカズ
5.1 アメリカズにおける化粧品用筋弛緩剤の売上、国別
5.1.1 アメリカズにおける化粧品用筋弛緩剤の売上規模、国別（2018年～2023年）
5.1.2 アメリカズにおける化粧品用筋弛緩剤市場の収益規模、国別（2018年～2023年）
5.2 アメリカズにおける化粧品用筋弛緩剤の売上、タイプ別
5.3 アメリカズにおける化粧品用筋弛緩剤の売上、用途別
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおける化粧品用筋弛緩剤の売上、地域別
6.1.1 APACにおける化粧品用筋弛緩剤の売上規模、地域別（2018年～2023年）
6.1.2 APACにおける化粧品用筋弛緩剤市場の収益規模、地域別（2018年～2023年）
6.2 APACにおける化粧品用筋弛緩剤の売上、タイプ別
6.3 APACにおける化粧品用筋弛緩剤の売上、用途別
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
6.10 中国の台湾
7 ヨーロッパ
7.1 ヨーロッパにおける化粧品用筋弛緩剤、国別
7.1.1 ヨーロッパにおける化粧品用筋弛緩剤の売上規模、国別（2018年～2023年）
7.1.2 ヨーロッパにおける化粧品用筋弛緩剤市場の収益規模、国別（2018年～2023年）
7.2 ヨーロッパにおける化粧品用筋弛緩剤の売上、タイプ別
7.3 ヨーロッパにおける化粧品用筋弛緩剤の売上、用途別
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカにおける化粧品用筋弛緩剤、国別
8.1.1 中東・アフリカにおける化粧品用筋弛緩剤の売上規模、国別（2018年～2023年）
8.1.2 中東・アフリカにおける化粧品用筋弛緩剤市場の収益規模、国別（2018年～2023年）
8.2 中東・アフリカにおける化粧品用筋弛緩剤の売上、タイプ別
8.3 中東・アフリカにおける化粧品用筋弛緩剤の売上、用途別
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 製造コスト構造分析
10.1 原料・サプライヤー
10.2 化粧品用筋弛緩剤の製造コスト構造分析
10.3 化粧品用筋弛緩剤の製造プロセス分析
10.4 化粧品用筋弛緩剤のインダストリーチェーン構造
11 マーケティング・流通・顧客
11.1 販売チャネル
11.1.1 直接チャネル
11.1.2 間接チャネル
11.2 化粧品用筋弛緩剤の流通業者
11.3 化粧品用筋弛緩剤の顧客
12 化粧品用筋弛緩剤の世界市場予測レビュー、地理別
12.1 グローバルにおける化粧品用筋弛緩剤の市場規模予測、地域別
12.1.1 グローバルの化粧品用筋弛緩剤、市場予測（地域別）（2024年～2029年）
12.1.2 グローバルの化粧品用筋弛緩剤、年間収益予測（地域別）（2024年～2029年）
12.2 アメリカズにおける予測、国別
12.3 APACにおける予測、地域別
12.4 ヨーロッパにおける予測、国別
12.5 中東・アフリカにおける予測、国別
12.6 グローバルにおける化粧品用筋弛緩剤の市場予測、タイプ別
12.7 グローバルにおける化粧品用筋弛緩剤の市場予測、用途別
13 キープレイヤー分析
13.1 All Organic Treasures
13.1.1 All Organic Treasures：企業情報
13.1.2 All Organic Treasures：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.1.3 All Organic Treasures：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.1.4 All Organic Treasures：主要事業概要
13.1.5 All Organic Treasures：直近の展開
13.2 BioOrganic Concepts
13.2.1 BioOrganic Concepts：企業情報
13.2.2 BioOrganic Concepts：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.2.3 BioOrganic Concepts：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.2.4 BioOrganic Concepts：主要事業概要
13.2.5 BioOrganic Concepts：直近の展開
13.3 Biogründl
13.3.1 Biogründl：企業情報
13.3.2 Biogründl：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.3.3 Biogründl：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.3.4 Biogründl：主要事業概要
13.3.5 Biogründl：直近の展開
13.4 Botanic Innovations
13.4.1 Botanic Innovations：企業情報
13.4.2 Botanic Innovations：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.4.3 Botanic Innovations：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.4.4 Botanic Innovations：主要事業概要
13.4.5 Botanic Innovations：直近の展開
13.5 Chemir
13.5.1 Chemir：企業情報
13.5.2 Chemir：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.5.3 Chemir：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.5.4 Chemir：主要事業概要
13.5.5 Chemir：直近の展開
13.6 Esperis
13.6.1 Esperis：企業情報
13.6.2 Esperis：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.6.3 Esperis：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.6.4 Esperis：主要事業概要
13.6.5 Esperis：直近の展開
13.7 Gattefossé
13.7.1 Gattefossé：企業情報
13.7.2 Gattefossé：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.7.3 Gattefossé：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.7.4 Gattefossé：主要事業概要
13.7.5 Gattefossé：直近の展開
13.8 Givaudan
13.8.1 Givaudan：企業情報
13.8.2 Givaudan：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.8.3 Givaudan：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.8.4 Givaudan：主要事業概要
13.8.5 Givaudan：直近の展開
13.9 Green Angel
13.9.1 Green Angel：企業情報
13.9.2 Green Angel：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.9.3 Green Angel：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.9.4 Green Angel：主要事業概要
13.9.5 Green Angel：直近の展開
13.10 Green Source Organics
13.10.1 Green Source Organics：企業情報
13.10.2 Green Source Organics：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.10.3 Green Source Organics：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.10.4 Green Source Organics：主要事業概要
13.10.5 Green Source Organics：直近の展開
13.11 Linnea
13.11.1 Linnea：企業情報
13.11.2 Linnea：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.11.3 Linnea：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.11.4 Linnea：主要事業概要
13.11.5 Linnea：直近の展開
13.12 Lubrizol
13.12.1 Lubrizol：企業情報
13.12.2 Lubrizol：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.12.3 Lubrizol：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.12.4 Lubrizol：主要事業概要
13.12.5 Lubrizol：直近の展開
13.13 Macrocare Tech
13.13.1 Macrocare Tech：企業情報
13.13.2 Macrocare Tech：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.13.3 Macrocare Tech：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.13.4 Macrocare Tech：主要事業概要
13.13.5 Macrocare Tech：直近の展開
13.14 Phyto Life Sciences
13.14.1 Phyto Life Sciences：企業情報
13.14.2 Phyto Life Sciences：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.14.3 Phyto Life Sciences：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.14.4 Phyto Life Sciences：主要事業概要
13.14.5 Phyto Life Sciences：直近の展開
13.15 Sensient Cosmetic Technologies
13.15.1 Sensient Cosmetic Technologies：企業情報
13.15.2 Sensient Cosmetic Technologies：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.15.3 Sensient Cosmetic Technologies：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.15.4 Sensient Cosmetic Technologies：主要事業概要
13.15.5 Sensient Cosmetic Technologies：直近の展開
13.16 Hunan Health-Guard Bio-Tech
13.16.1 Hunan Health-Guard Bio-Tech：企業情報
13.16.2 Hunan Health-Guard Bio-Tech：化粧品用筋弛緩剤製品ポートフォリオと特徴
13.16.3 Hunan Health-Guard Bio-Tech：化粧品用筋弛緩剤売上・収益・価格およびグロスマージン（2018年～2023年）
13.16.4 Hunan Health-Guard Bio-Tech：主要事業概要
13.16.5 Hunan Health-Guard Bio-Tech：直近の展開
14 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
LPI (LP Information)' newest research report, the “Myorelaxing Agents for Cosmetics Industry Forecast” looks at past sales and reviews total world Myorelaxing Agents for Cosmetics sales in 2022, providing a comprehensive analysis by region and market sector of projected Myorelaxing Agents for Cosmetics sales for 2023 through 2029. With Myorelaxing Agents for Cosmetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Myorelaxing Agents for Cosmetics industry.
This Insight Report provides a comprehensive analysis of the global Myorelaxing Agents for Cosmetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Myorelaxing Agents for Cosmetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Myorelaxing Agents for Cosmetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Myorelaxing Agents for Cosmetics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Myorelaxing Agents for Cosmetics.
The global Myorelaxing Agents for Cosmetics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Myorelaxing Agents for Cosmetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Myorelaxing Agents for Cosmetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Myorelaxing Agents for Cosmetics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Myorelaxing Agents for Cosmetics players cover All Organic Treasures, BioOrganic Concepts, Biogründl, Botanic Innovations, Chemir, Esperis, Gattefossé, Givaudan and Green Angel, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Myorelaxing Agents for Cosmetics market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Plant Petal Extract
Plant Seed Extract
Other
Segmentation by application
Men's Cosmetics
Ladies Cosmetics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
All Organic Treasures
BioOrganic Concepts
Biogründl
Botanic Innovations
Chemir
Esperis
Gattefossé
Givaudan
Green Angel
Green Source Organics
Linnea
Lubrizol
Macrocare Tech
Phyto Life Sciences
Sensient Cosmetic Technologies
Hunan Health-Guard Bio-Tech
Key Questions Addressed in this Report
What is the 10-year outlook for the global Myorelaxing Agents for Cosmetics market?
What factors are driving Myorelaxing Agents for Cosmetics market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Myorelaxing Agents for Cosmetics market opportunities vary by end market size?
How does Myorelaxing Agents for Cosmetics break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Myorelaxing Agents for Cosmetics Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Myorelaxing Agents for Cosmetics by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Myorelaxing Agents for Cosmetics by Country/Region, 2018, 2022 & 2029
2.2 Myorelaxing Agents for Cosmetics Segment by Type
2.2.1 Plant Petal Extract
2.2.2 Plant Seed Extract
2.2.3 Other
2.3 Myorelaxing Agents for Cosmetics Sales by Type
2.3.1 Global Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023)
2.3.2 Global Myorelaxing Agents for Cosmetics Revenue and Market Share by Type (2018-2023)
2.3.3 Global Myorelaxing Agents for Cosmetics Sale Price by Type (2018-2023)
2.4 Myorelaxing Agents for Cosmetics Segment by Application
2.4.1 Men's Cosmetics
2.4.2 Ladies Cosmetics
2.5 Myorelaxing Agents for Cosmetics Sales by Application
2.5.1 Global Myorelaxing Agents for Cosmetics Sale Market Share by Application (2018-2023)
2.5.2 Global Myorelaxing Agents for Cosmetics Revenue and Market Share by Application (2018-2023)
2.5.3 Global Myorelaxing Agents for Cosmetics Sale Price by Application (2018-2023)
3 Global Myorelaxing Agents for Cosmetics by Company
3.1 Global Myorelaxing Agents for Cosmetics Breakdown Data by Company
3.1.1 Global Myorelaxing Agents for Cosmetics Annual Sales by Company (2018-2023)
3.1.2 Global Myorelaxing Agents for Cosmetics Sales Market Share by Company (2018-2023)
3.2 Global Myorelaxing Agents for Cosmetics Annual Revenue by Company (2018-2023)
3.2.1 Global Myorelaxing Agents for Cosmetics Revenue by Company (2018-2023)
3.2.2 Global Myorelaxing Agents for Cosmetics Revenue Market Share by Company (2018-2023)
3.3 Global Myorelaxing Agents for Cosmetics Sale Price by Company
3.4 Key Manufacturers Myorelaxing Agents for Cosmetics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Myorelaxing Agents for Cosmetics Product Location Distribution
3.4.2 Players Myorelaxing Agents for Cosmetics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Myorelaxing Agents for Cosmetics by Geographic Region
4.1 World Historic Myorelaxing Agents for Cosmetics Market Size by Geographic Region (2018-2023)
4.1.1 Global Myorelaxing Agents for Cosmetics Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Myorelaxing Agents for Cosmetics Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Myorelaxing Agents for Cosmetics Market Size by Country/Region (2018-2023)
4.2.1 Global Myorelaxing Agents for Cosmetics Annual Sales by Country/Region (2018-2023)
4.2.2 Global Myorelaxing Agents for Cosmetics Annual Revenue by Country/Region (2018-2023)
4.3 Americas Myorelaxing Agents for Cosmetics Sales Growth
4.4 APAC Myorelaxing Agents for Cosmetics Sales Growth
4.5 Europe Myorelaxing Agents for Cosmetics Sales Growth
4.6 Middle East & Africa Myorelaxing Agents for Cosmetics Sales Growth
5 Americas
5.1 Americas Myorelaxing Agents for Cosmetics Sales by Country
5.1.1 Americas Myorelaxing Agents for Cosmetics Sales by Country (2018-2023)
5.1.2 Americas Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023)
5.2 Americas Myorelaxing Agents for Cosmetics Sales by Type
5.3 Americas Myorelaxing Agents for Cosmetics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Myorelaxing Agents for Cosmetics Sales by Region
6.1.1 APAC Myorelaxing Agents for Cosmetics Sales by Region (2018-2023)
6.1.2 APAC Myorelaxing Agents for Cosmetics Revenue by Region (2018-2023)
6.2 APAC Myorelaxing Agents for Cosmetics Sales by Type
6.3 APAC Myorelaxing Agents for Cosmetics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Myorelaxing Agents for Cosmetics by Country
7.1.1 Europe Myorelaxing Agents for Cosmetics Sales by Country (2018-2023)
7.1.2 Europe Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023)
7.2 Europe Myorelaxing Agents for Cosmetics Sales by Type
7.3 Europe Myorelaxing Agents for Cosmetics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Myorelaxing Agents for Cosmetics by Country
8.1.1 Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Country (2018-2023)
8.1.2 Middle East & Africa Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023)
8.2 Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Type
8.3 Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Myorelaxing Agents for Cosmetics
10.3 Manufacturing Process Analysis of Myorelaxing Agents for Cosmetics
10.4 Industry Chain Structure of Myorelaxing Agents for Cosmetics
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Myorelaxing Agents for Cosmetics Distributors
11.3 Myorelaxing Agents for Cosmetics Customer
12 World Forecast Review for Myorelaxing Agents for Cosmetics by Geographic Region
12.1 Global Myorelaxing Agents for Cosmetics Market Size Forecast by Region
12.1.1 Global Myorelaxing Agents for Cosmetics Forecast by Region (2024-2029)
12.1.2 Global Myorelaxing Agents for Cosmetics Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Myorelaxing Agents for Cosmetics Forecast by Type
12.7 Global Myorelaxing Agents for Cosmetics Forecast by Application
13 Key Players Analysis
13.1 All Organic Treasures
13.1.1 All Organic Treasures Company Information
13.1.2 All Organic Treasures Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.1.3 All Organic Treasures Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 All Organic Treasures Main Business Overview
13.1.5 All Organic Treasures Latest Developments
13.2 BioOrganic Concepts
13.2.1 BioOrganic Concepts Company Information
13.2.2 BioOrganic Concepts Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.2.3 BioOrganic Concepts Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 BioOrganic Concepts Main Business Overview
13.2.5 BioOrganic Concepts Latest Developments
13.3 Biogründl
13.3.1 Biogründl Company Information
13.3.2 Biogründl Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.3.3 Biogründl Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Biogründl Main Business Overview
13.3.5 Biogründl Latest Developments
13.4 Botanic Innovations
13.4.1 Botanic Innovations Company Information
13.4.2 Botanic Innovations Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.4.3 Botanic Innovations Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Botanic Innovations Main Business Overview
13.4.5 Botanic Innovations Latest Developments
13.5 Chemir
13.5.1 Chemir Company Information
13.5.2 Chemir Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.5.3 Chemir Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Chemir Main Business Overview
13.5.5 Chemir Latest Developments
13.6 Esperis
13.6.1 Esperis Company Information
13.6.2 Esperis Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.6.3 Esperis Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Esperis Main Business Overview
13.6.5 Esperis Latest Developments
13.7 Gattefossé
13.7.1 Gattefossé Company Information
13.7.2 Gattefossé Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.7.3 Gattefossé Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Gattefossé Main Business Overview
13.7.5 Gattefossé Latest Developments
13.8 Givaudan
13.8.1 Givaudan Company Information
13.8.2 Givaudan Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.8.3 Givaudan Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Givaudan Main Business Overview
13.8.5 Givaudan Latest Developments
13.9 Green Angel
13.9.1 Green Angel Company Information
13.9.2 Green Angel Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.9.3 Green Angel Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Green Angel Main Business Overview
13.9.5 Green Angel Latest Developments
13.10 Green Source Organics
13.10.1 Green Source Organics Company Information
13.10.2 Green Source Organics Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.10.3 Green Source Organics Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Green Source Organics Main Business Overview
13.10.5 Green Source Organics Latest Developments
13.11 Linnea
13.11.1 Linnea Company Information
13.11.2 Linnea Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.11.3 Linnea Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Linnea Main Business Overview
13.11.5 Linnea Latest Developments
13.12 Lubrizol
13.12.1 Lubrizol Company Information
13.12.2 Lubrizol Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.12.3 Lubrizol Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Lubrizol Main Business Overview
13.12.5 Lubrizol Latest Developments
13.13 Macrocare Tech
13.13.1 Macrocare Tech Company Information
13.13.2 Macrocare Tech Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.13.3 Macrocare Tech Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Macrocare Tech Main Business Overview
13.13.5 Macrocare Tech Latest Developments
13.14 Phyto Life Sciences
13.14.1 Phyto Life Sciences Company Information
13.14.2 Phyto Life Sciences Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.14.3 Phyto Life Sciences Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Phyto Life Sciences Main Business Overview
13.14.5 Phyto Life Sciences Latest Developments
13.15 Sensient Cosmetic Technologies
13.15.1 Sensient Cosmetic Technologies Company Information
13.15.2 Sensient Cosmetic Technologies Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.15.3 Sensient Cosmetic Technologies Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sensient Cosmetic Technologies Main Business Overview
13.15.5 Sensient Cosmetic Technologies Latest Developments
13.16 Hunan Health-Guard Bio-Tech
13.16.1 Hunan Health-Guard Bio-Tech Company Information
13.16.2 Hunan Health-Guard Bio-Tech Myorelaxing Agents for Cosmetics Product Portfolios and Specifications
13.16.3 Hunan Health-Guard Bio-Tech Myorelaxing Agents for Cosmetics Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Hunan Health-Guard Bio-Tech Main Business Overview
13.16.5 Hunan Health-Guard Bio-Tech Latest Developments
14 Research Findings and Conclusion
List of Tables Table 1. Myorelaxing Agents for Cosmetics Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions) Table 2. Myorelaxing Agents for Cosmetics Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions) Table 3. Major Players of Plant Petal Extract Table 4. Major Players of Plant Seed Extract Table 5. Major Players of Other Table 6. Global Myorelaxing Agents for Cosmetics Sales by Type (2018-2023) & (Tons) Table 7. Global Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023) Table 8. Global Myorelaxing Agents for Cosmetics Revenue by Type (2018-2023) & ($ million) Table 9. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Type (2018-2023) Table 10. Global Myorelaxing Agents for Cosmetics Sale Price by Type (2018-2023) & (US$/Ton) Table 11. Global Myorelaxing Agents for Cosmetics Sales by Application (2018-2023) & (Tons) Table 12. Global Myorelaxing Agents for Cosmetics Sales Market Share by Application (2018-2023) Table 13. Global Myorelaxing Agents for Cosmetics Revenue by Application (2018-2023) Table 14. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Application (2018-2023) Table 15. Global Myorelaxing Agents for Cosmetics Sale Price by Application (2018-2023) & (US$/Ton) Table 16. Global Myorelaxing Agents for Cosmetics Sales by Company (2018-2023) & (Tons) Table 17. Global Myorelaxing Agents for Cosmetics Sales Market Share by Company (2018-2023) Table 18. Global Myorelaxing Agents for Cosmetics Revenue by Company (2018-2023) ($ Millions) Table 19. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Company (2018-2023) Table 20. Global Myorelaxing Agents for Cosmetics Sale Price by Company (2018-2023) & (US$/Ton) Table 21. Key Manufacturers Myorelaxing Agents for Cosmetics Producing Area Distribution and Sales Area Table 22. Players Myorelaxing Agents for Cosmetics Products Offered Table 23. Myorelaxing Agents for Cosmetics Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) Table 24. New Products and Potential Entrants Table 25. Mergers & Acquisitions, Expansion Table 26. Global Myorelaxing Agents for Cosmetics Sales by Geographic Region (2018-2023) & (Tons) Table 27. Global Myorelaxing Agents for Cosmetics Sales Market Share Geographic Region (2018-2023) Table 28. Global Myorelaxing Agents for Cosmetics Revenue by Geographic Region (2018-2023) & ($ millions) Table 29. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Geographic Region (2018-2023) Table 30. Global Myorelaxing Agents for Cosmetics Sales by Country/Region (2018-2023) & (Tons) Table 31. Global Myorelaxing Agents for Cosmetics Sales Market Share by Country/Region (2018-2023) Table 32. Global Myorelaxing Agents for Cosmetics Revenue by Country/Region (2018-2023) & ($ millions) Table 33. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Country/Region (2018-2023) Table 34. Americas Myorelaxing Agents for Cosmetics Sales by Country (2018-2023) & (Tons) Table 35. Americas Myorelaxing Agents for Cosmetics Sales Market Share by Country (2018-2023) Table 36. Americas Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023) & ($ Millions) Table 37. Americas Myorelaxing Agents for Cosmetics Revenue Market Share by Country (2018-2023) Table 38. Americas Myorelaxing Agents for Cosmetics Sales by Type (2018-2023) & (Tons) Table 39. Americas Myorelaxing Agents for Cosmetics Sales by Application (2018-2023) & (Tons) Table 40. APAC Myorelaxing Agents for Cosmetics Sales by Region (2018-2023) & (Tons) Table 41. APAC Myorelaxing Agents for Cosmetics Sales Market Share by Region (2018-2023) Table 42. APAC Myorelaxing Agents for Cosmetics Revenue by Region (2018-2023) & ($ Millions) Table 43. APAC Myorelaxing Agents for Cosmetics Revenue Market Share by Region (2018-2023) Table 44. APAC Myorelaxing Agents for Cosmetics Sales by Type (2018-2023) & (Tons) Table 45. APAC Myorelaxing Agents for Cosmetics Sales by Application (2018-2023) & (Tons) Table 46. Europe Myorelaxing Agents for Cosmetics Sales by Country (2018-2023) & (Tons) Table 47. Europe Myorelaxing Agents for Cosmetics Sales Market Share by Country (2018-2023) Table 48. Europe Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023) & ($ Millions) Table 49. Europe Myorelaxing Agents for Cosmetics Revenue Market Share by Country (2018-2023) Table 50. Europe Myorelaxing Agents for Cosmetics Sales by Type (2018-2023) & (Tons) Table 51. Europe Myorelaxing Agents for Cosmetics Sales by Application (2018-2023) & (Tons) Table 52. Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Country (2018-2023) & (Tons) Table 53. Middle East & Africa Myorelaxing Agents for Cosmetics Sales Market Share by Country (2018-2023) Table 54. Middle East & Africa Myorelaxing Agents for Cosmetics Revenue by Country (2018-2023) & ($ Millions) Table 55. Middle East & Africa Myorelaxing Agents for Cosmetics Revenue Market Share by Country (2018-2023) Table 56. Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Type (2018-2023) & (Tons) Table 57. Middle East & Africa Myorelaxing Agents for Cosmetics Sales by Application (2018-2023) & (Tons) Table 58. Key Market Drivers & Growth Opportunities of Myorelaxing Agents for Cosmetics Table 59. Key Market Challenges & Risks of Myorelaxing Agents for Cosmetics Table 60. Key Industry Trends of Myorelaxing Agents for Cosmetics Table 61. Myorelaxing Agents for Cosmetics Raw Material Table 62. Key Suppliers of Raw Materials Table 63. Myorelaxing Agents for Cosmetics Distributors List Table 64. Myorelaxing Agents for Cosmetics Customer List Table 65. Global Myorelaxing Agents for Cosmetics Sales Forecast by Region (2024-2029) & (Tons) Table 66. Global Myorelaxing Agents for Cosmetics Revenue Forecast by Region (2024-2029) & ($ millions) Table 67. Americas Myorelaxing Agents for Cosmetics Sales Forecast by Country (2024-2029) & (Tons) Table 68. Americas Myorelaxing Agents for Cosmetics Revenue Forecast by Country (2024-2029) & ($ millions) Table 69. APAC Myorelaxing Agents for Cosmetics Sales Forecast by Region (2024-2029) & (Tons) Table 70. APAC Myorelaxing Agents for Cosmetics Revenue Forecast by Region (2024-2029) & ($ millions) Table 71. Europe Myorelaxing Agents for Cosmetics Sales Forecast by Country (2024-2029) & (Tons) Table 72. Europe Myorelaxing Agents for Cosmetics Revenue Forecast by Country (2024-2029) & ($ millions) Table 73. Middle East & Africa Myorelaxing Agents for Cosmetics Sales Forecast by Country (2024-2029) & (Tons) Table 74. Middle East & Africa Myorelaxing Agents for Cosmetics Revenue Forecast by Country (2024-2029) & ($ millions) Table 75. Global Myorelaxing Agents for Cosmetics Sales Forecast by Type (2024-2029) & (Tons) Table 76. Global Myorelaxing Agents for Cosmetics Revenue Forecast by Type (2024-2029) & ($ Millions) Table 77. Global Myorelaxing Agents for Cosmetics Sales Forecast by Application (2024-2029) & (Tons) Table 78. Global Myorelaxing Agents for Cosmetics Revenue Forecast by Application (2024-2029) & ($ Millions) Table 79. All Organic Treasures Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 80. All Organic Treasures Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 81. All Organic Treasures Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 82. All Organic Treasures Main Business Table 83. All Organic Treasures Latest Developments Table 84. BioOrganic Concepts Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 85. BioOrganic Concepts Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 86. BioOrganic Concepts Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 87. BioOrganic Concepts Main Business Table 88. BioOrganic Concepts Latest Developments Table 89. Biogründl Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 90. Biogründl Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 91. Biogründl Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 92. Biogründl Main Business Table 93. Biogründl Latest Developments Table 94. Botanic Innovations Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 95. Botanic Innovations Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 96. Botanic Innovations Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 97. Botanic Innovations Main Business Table 98. Botanic Innovations Latest Developments Table 99. Chemir Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 100. Chemir Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 101. Chemir Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 102. Chemir Main Business Table 103. Chemir Latest Developments Table 104. Esperis Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 105. Esperis Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 106. Esperis Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 107. Esperis Main Business Table 108. Esperis Latest Developments Table 109. Gattefossé Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 110. Gattefossé Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 111. Gattefossé Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 112. Gattefossé Main Business Table 113. Gattefossé Latest Developments Table 114. Givaudan Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 115. Givaudan Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 116. Givaudan Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 117. Givaudan Main Business Table 118. Givaudan Latest Developments Table 119. Green Angel Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 120. Green Angel Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 121. Green Angel Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 122. Green Angel Main Business Table 123. Green Angel Latest Developments Table 124. Green Source Organics Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 125. Green Source Organics Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 126. Green Source Organics Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 127. Green Source Organics Main Business Table 128. Green Source Organics Latest Developments Table 129. Linnea Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 130. Linnea Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 131. Linnea Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 132. Linnea Main Business Table 133. Linnea Latest Developments Table 134. Lubrizol Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 135. Lubrizol Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 136. Lubrizol Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 137. Lubrizol Main Business Table 138. Lubrizol Latest Developments Table 139. Macrocare Tech Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 140. Macrocare Tech Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 141. Macrocare Tech Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 142. Macrocare Tech Main Business Table 143. Macrocare Tech Latest Developments Table 144. Phyto Life Sciences Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 145. Phyto Life Sciences Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 146. Phyto Life Sciences Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 147. Phyto Life Sciences Main Business Table 148. Phyto Life Sciences Latest Developments Table 149. Sensient Cosmetic Technologies Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 150. Sensient Cosmetic Technologies Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 151. Sensient Cosmetic Technologies Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 152. Sensient Cosmetic Technologies Main Business Table 153. Sensient Cosmetic Technologies Latest Developments Table 154. Hunan Health-Guard Bio-Tech Basic Information, Myorelaxing Agents for Cosmetics Manufacturing Base, Sales Area and Its Competitors Table 155. Hunan Health-Guard Bio-Tech Myorelaxing Agents for Cosmetics Product Portfolios and Specifications Table 156. Hunan Health-Guard Bio-Tech Myorelaxing Agents for Cosmetics Sales (Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023) Table 157. Hunan Health-Guard Bio-Tech Main Business Table 158. Hunan Health-Guard Bio-Tech Latest Developments List of Figures Figure 1. Picture of Myorelaxing Agents for Cosmetics Figure 2. Myorelaxing Agents for Cosmetics Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Myorelaxing Agents for Cosmetics Sales Growth Rate 2018-2029 (Tons) Figure 7. Global Myorelaxing Agents for Cosmetics Revenue Growth Rate 2018-2029 ($ Millions) Figure 8. Myorelaxing Agents for Cosmetics Sales by Region (2018, 2022 & 2029) & ($ Millions) Figure 9. Product Picture of Plant Petal Extract Figure 10. Product Picture of Plant Seed Extract Figure 11. Product Picture of Other Figure 12. Global Myorelaxing Agents for Cosmetics Sales Market Share by Type in 2022 Figure 13. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Type (2018-2023) Figure 14. Myorelaxing Agents for Cosmetics Consumed in Men's Cosmetics Figure 15. Global Myorelaxing Agents for Cosmetics Market: Men's Cosmetics (2018-2023) & (Tons) Figure 16. Myorelaxing Agents for Cosmetics Consumed in Ladies Cosmetics Figure 17. Global Myorelaxing Agents for Cosmetics Market: Ladies Cosmetics (2018-2023) & (Tons) Figure 18. Global Myorelaxing Agents for Cosmetics Sales Market Share by Application (2022) Figure 19. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Application in 2022 Figure 20. Myorelaxing Agents for Cosmetics Sales Market by Company in 2022 (Tons) Figure 21. Global Myorelaxing Agents for Cosmetics Sales Market Share by Company in 2022 Figure 22. Myorelaxing Agents for Cosmetics Revenue Market by Company in 2022 ($ Million) Figure 23. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Company in 2022 Figure 24. Global Myorelaxing Agents for Cosmetics Sales Market Share by Geographic Region (2018-2023) Figure 25. Global Myorelaxing Agents for Cosmetics Revenue Market Share by Geographic Region in 2022 Figure 26. Americas Myorelaxing Agents for Cosmetics Sales 2018-2023 (Tons) Figure 27. Americas Myorelaxing Agents for Cosmetics Revenue 2018-2023 ($ Millions) Figure 28. APAC Myorelaxing Agents for Cosmetics Sales 2018-2023 (Tons) Figure 29. APAC Myorelaxing Agents for Cosmetics Revenue 2018-2023 ($ Millions) Figure 30. Europe Myorelaxing Agents for Cosmetics Sales 2018-2023 (Tons) Figure 31. Europe Myorelaxing Agents for Cosmetics Revenue 2018-2023 ($ Millions) Figure 32. Middle East & Africa Myorelaxing Agents for Cosmetics Sales 2018-2023 (Tons) Figure 33. Middle East & Africa Myorelaxing Agents for Cosmetics Revenue 2018-2023 ($ Millions) Figure 34. Americas Myorelaxing Agents for Cosmetics Sales Market Share by Country in 2022 Figure 35. Americas Myorelaxing Agents for Cosmetics Revenue Market Share by Country in 2022 Figure 36. Americas Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023) Figure 37. Americas Myorelaxing Agents for Cosmetics Sales Market Share by Application (2018-2023) Figure 38. United States Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 39. Canada Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 40. Mexico Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 41. Brazil Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 42. APAC Myorelaxing Agents for Cosmetics Sales Market Share by Region in 2022 Figure 43. APAC Myorelaxing Agents for Cosmetics Revenue Market Share by Regions in 2022 Figure 44. APAC Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023) Figure 45. APAC Myorelaxing Agents for Cosmetics Sales Market Share by Application (2018-2023) Figure 46. China Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 47. Japan Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 48. South Korea Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 49. Southeast Asia Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 50. India Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 51. Australia Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 52. China Taiwan Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 53. Europe Myorelaxing Agents for Cosmetics Sales Market Share by Country in 2022 Figure 54. Europe Myorelaxing Agents for Cosmetics Revenue Market Share by Country in 2022 Figure 55. Europe Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023) Figure 56. Europe Myorelaxing Agents for Cosmetics Sales Market Share by Application (2018-2023) Figure 57. Germany Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 58. France Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 59. UK Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 60. Italy Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 61. Russia Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 62. Middle East & Africa Myorelaxing Agents for Cosmetics Sales Market Share by Country in 2022 Figure 63. Middle East & Africa Myorelaxing Agents for Cosmetics Revenue Market Share by Country in 2022 Figure 64. Middle East & Africa Myorelaxing Agents for Cosmetics Sales Market Share by Type (2018-2023) Figure 65. Middle East & Africa Myorelaxing Agents for Cosmetics Sales Market Share by Application (2018-2023) Figure 66. Egypt Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 67. South Africa Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 68. Israel Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 69. Turkey Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 70. GCC Country Myorelaxing Agents for Cosmetics Revenue Growth 2018-2023 ($ Millions) Figure 71. Manufacturing Cost Structure Analysis of Myorelaxing Agents for Cosmetics in 2022 Figure 72. Manufacturing Process Analysis of Myorelaxing Agents for Cosmetics Figure 73. Industry Chain Structure of Myorelaxing Agents for Cosmetics Figure 74. Channels of Distribution Figure 75. Global Myorelaxing Agents for Cosmetics Sales Market Forecast by Region (2024-2029) Figure 76. Global Myorelaxing Agents for Cosmetics Revenue Market Share Forecast by Region (2024-2029) Figure 77. Global Myorelaxing Agents for Cosmetics Sales Market Share Forecast by Type (2024-2029) Figure 78. Global Myorelaxing Agents for Cosmetics Revenue Market Share Forecast by Type (2024-2029) Figure 79. Global Myorelaxing Agents for Cosmetics Sales Market Share Forecast by Application (2024-2029) Figure 80. Global Myorelaxing Agents for Cosmetics Revenue Market Share Forecast by Application (2024-2029)
